Bryan Brewer
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 1%
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism
Papers in
-
- Peroxisome Proliferator-Activated Receptors 5
- Surgery 9
- Cholesterol and Lipid Metabolism 8
- Lipoproteins and Cardiovascular Health 3
- Co-authors
- Alan R. Tall (2 shared papers)Jean‐Claude Tardif (1 shared paper)Charles L. Shear (1 shared paper)Mark J. Caulfield (1 shared paper)Marian R. Fisher (1 shared paper)Michel Komajda (1 shared paper)David D. Waters (1 shared paper)Kevin A. Buhr (1 shared paper)
- Journals
- Journal of Biological Chemistry (4 papers)Journal of Clinical Investigation (2 papers)Blood (2 papers)Circulation (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- United StatesFranceAustralia
In The Last Decade
Bryan Brewer
19 papers receiving 4.0k citations
Bryan Brewer's Hit Papers
Peers
Comparison fields: 5 of 117
- Endocrinology, Diabetes and Metabolism 1.2k
- Surgery 1.6k
- Cancer Research 448
- Biochemistry 208
- Cardiology and Cardiovascular Medicine 578
Countries citing papers authored by Bryan Brewer
This map shows the geographic impact of Bryan Brewer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Brewer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Brewer more than expected).
Fields of papers citing papers by Bryan Brewer
This network shows the impact of papers produced by Bryan Brewer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Brewer. The network helps show where Bryan Brewer may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan Brewer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effects of Torcetrapib in Patients at High Risk for Coronary Events Hit paper breakdown → | 2007 | 2239 |
| 2 | 2003 | 478 | |
| 3 | 2003 | 476 | |
| 4 | 1995 | 196 | |
| 5 | 2004 | 173 | |
| 6 | 1982 | 155 | |
| 7 | 2006 | 111 | |
| 8 | 1974 | 78 | |
| 9 | 2004 | 66 | |
| 10 | 1998 | 49 | |
| 11 | 2001 | 29 | |
| 12 | 2001 | 24 | |
| 13 | 1997 | 23 | |
| 14 | 2008 | 16 | |
| 15 | 2001 | 15 | |
| 16 | 1995 | 8 | |
| 17 | 2014 | 6 | |
| 18 | 1998 | 6 | |
| 19 | 2017 | 1 |
About Bryan Brewer
Bryan Brewer is a scholar working on Molecular Biology, Surgery, Oncology, Endocrinology, Diabetes and Metabolism and Immunology, having authored 19 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (8 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Drug Transport and Resistance Mechanisms (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Clusterin in disease pathology (2 papers) and Renal Diseases and Glomerulopathies (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Surgery (1.6k citations), Cancer Research (448 citations), Biochemistry (208 citations) and Cardiology and Cardiovascular Medicine (578 citations). Bryan Brewer has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Alan R. Tall, Jean‐Claude Tardif, Charles L. Shear, Mark J. Caulfield, Marian R. Fisher, Michel Komajda, David D. Waters, Kevin A. Buhr, Scott M. Grundy and John J.P. Kastelein. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation, Blood, Circulation and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.